Log in

NASDAQ:MGLN - Magellan Health Stock Price, Forecast & News

-1.84 (-4.01 %)
(As of 03/29/2020 05:20 AM ET)
Today's Range
Now: $44.06
50-Day Range
MA: $59.41
52-Week Range
Now: $44.06
Volume199,063 shs
Average Volume307,258 shs
Market Capitalization$1.09 billion
P/E Ratio19.32
Dividend YieldN/A
Magellan Health, Inc. provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. It offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.
Read More
Magellan Health logo

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
Current SymbolNASDAQ:MGLN



Sales & Book Value

Annual Sales$7.16 billion
Cash Flow$8.74 per share
Book Value$57.13 per share


Net Income$55.90 million


Market Cap$1.09 billion
Next Earnings Date5/7/2020 (Estimated)

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

How has Magellan Health's stock been impacted by COVID-19 (Coronavirus)?

Magellan Health's stock was trading at $53.88 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MGLN stock has decreased by 18.2% and is now trading at $44.06. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Magellan Health?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Magellan Health.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Magellan Health.

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) announced its quarterly earnings data on Friday, February, 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.28. The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. Magellan Health had a return on equity of 6.81% and a net margin of 0.78%. Magellan Health's revenue for the quarter was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.77) earnings per share. View Magellan Health's earnings history.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY20 earnings guidance on Friday, February, 28th. The company provided earnings per share (EPS) guidance of $3.43-4.14 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.70. The company issued revenue guidance of $7.0-7.4 billion, compared to the consensus revenue estimate of $7.44 billion.

What price target have analysts set for MGLN?

1 analysts have issued 12 month price targets for Magellan Health's stock. Their forecasts range from $67.00 to $67.00. On average, they expect Magellan Health's share price to reach $67.00 in the next year. This suggests a possible upside of 52.1% from the stock's current price. View analysts' price targets for Magellan Health.

Has Magellan Health been receiving favorable news coverage?

Press coverage about MGLN stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Magellan Health earned a news impact score of 1.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutMagellan Health.

Are investors shorting Magellan Health?

Magellan Health saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 526,300 shares, an increase of 17.9% from the February 13th total of 446,300 shares. Based on an average daily trading volume, of 159,400 shares, the days-to-cover ratio is currently 3.3 days. Currently, 2.2% of the shares of the company are short sold. View Magellan Health's Current Options Chain.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), UnitedHealth Group (UNH), Netflix (NFLX), Ford Motor (F), Edwards Lifesciences (EW), General Motors (GM), AT&T (T), Boston Scientific (BSX), ConocoPhillips (COP) and Home Depot (HD).

Who are Magellan Health's key executives?

Magellan Health's management team includes the following people:
  • Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)
  • Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Victory Capital Management Inc. (4.94%), Victory Capital Management Inc. (4.12%), State Street Corp (3.63%), Renaissance Technologies LLC (2.75%), Norges Bank (1.43%) and Geode Capital Management LLC (1.35%). Company insiders that own Magellan Health stock include Barry M Smith and Jeffrey N West. View institutional ownership trends for Magellan Health.

Which institutional investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Snow Capital Management LP, William Blair Investment Management LLC, Russell Investments Group Ltd., SG Americas Securities LLC, FMR LLC, Chicago Equity Partners LLC, Bank of New York Mellon Corp, and AQR Capital Management LLC. View insider buying and selling activity for Magellan Health.

Which institutional investors are buying Magellan Health stock?

MGLN stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Norges Bank, Victory Capital Management Inc., Goldman Sachs Group Inc., Point72 Asset Management L.P., Voss Capital LLC, Renaissance Technologies LLC, and Marshall Wace LLP. View insider buying and selling activity for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $44.06.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.09 billion and generates $7.16 billion in revenue each year. The company earns $55.90 million in net income (profit) each year or $3.73 on an earnings per share basis. Magellan Health employs 10,100 workers across the globe. View additional information about Magellan Health.

What is Magellan Health's official website?

The official website for Magellan Health is http://www.magellanhealth.com/.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]

MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  357 (Vote Outperform)
Underperform Votes:  381 (Vote Underperform)
Total Votes:  738
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: Market Indexes

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel